paperKB
coga / coga-kb
Help
Sign in

Chunk #21 — Using intermediate phenotypes to find disease mechanisms

Source
Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease.
Embedded
yes

Text

Ignorance about causal relationships is not due to a lack of theories about important pathways. For example, for major depression we can identify at least seven: (i) alterations in cAMP signaling pathway [47], (ii) impaired corticosteroid receptor signaling [48], (iii) neurotrophins [49], (iv) alterations in fibroblast growth factors [50], (v) GABAergic deficits [51], (vi) epigenetic changes at glucocorticoid receptors and brain derived neurotrophic factor [52], and (vi) alterations in glutamate [53] and (vii) alterations in serotonin signaling [54]. Each theory suggests possibilities for collecting intermediate phenotypes, at multiple levels (for instance, measuring GABA and glutamate concentrations by proton magnetic resonance spectroscopy [55]). Since we know so little about the origins of psychiatric disease, we are left in the situation of collecting a large number of intermediate phenotypes in the hope that some might aid our understanding of the disease.